A detailed history of Erts Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Erts Wealth Advisors, LLC holds 1,330 shares of AMGN stock, worth $419,668. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,330
Previous 1,426 6.73%
Holding current value
$419,668
Previous $445,000 3.82%
% of portfolio
0.08%
Previous 0.09%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$309.38 - $337.38 $29,700 - $32,388
-96 Reduced 6.73%
1,330 $428,000
Q2 2024

Jul 18, 2024

SELL
$262.75 - $319.31 $1,576 - $1,915
-6 Reduced 0.42%
1,426 $445,000
Q1 2024

Apr 23, 2024

SELL
$268.87 - $324.56 $15,863 - $19,149
-59 Reduced 3.96%
1,432 $407,000
Q4 2023

Jan 23, 2024

BUY
$255.7 - $288.46 $11,250 - $12,692
44 Added 3.04%
1,491 $429,000
Q3 2023

Oct 16, 2023

SELL
$218.65 - $271.46 $1,967 - $2,443
-9 Reduced 0.62%
1,447 $388,000
Q2 2023

Jul 17, 2023

BUY
$214.27 - $253.37 $1,071 - $1,266
5 Added 0.34%
1,456 $323,000
Q1 2023

Apr 18, 2023

SELL
$225.79 - $275.2 $21,675 - $26,419
-96 Reduced 6.21%
1,451 $350,000
Q4 2022

Jan 27, 2023

SELL
$229.03 - $291.01 $229 - $291
-1 Reduced 0.06%
1,547 $406,000
Q3 2022

Nov 08, 2022

SELL
$224.46 - $253.15 $897 - $1,012
-4 Reduced 0.26%
1,548 $349,000
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $86,830 - $96,057
-396 Reduced 20.33%
1,552 $375,000
Q4 2021

Feb 15, 2022

BUY
$198.88 - $227.6 $2,784 - $3,186
14 Added 0.72%
1,948 $436,000
Q3 2021

Oct 13, 2021

SELL
$212.27 - $248.7 $7,217 - $8,455
-34 Reduced 1.73%
1,934 $411,000
Q1 2021

May 07, 2021

BUY
$221.91 - $258.6 $23,744 - $27,670
107 Added 5.75%
1,968 $490,000
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $216 - $257
1 Added 0.05%
1,861 $428,000
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $2,581 - $2,870
11 Added 0.59%
1,860 $473,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $90,201 - $110,689
-456 Reduced 19.78%
1,849 $436,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $82,919 - $109,973
-455 Reduced 16.49%
2,305 $467,000
Q4 2019

Feb 19, 2020

BUY
$189.21 - $243.2 $106,146 - $136,435
561 Added 25.51%
2,760 $665,000
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $82,495 - $106,035
-436 Reduced 16.55%
2,199 $428,000
Q3 2019

Nov 05, 2019

BUY
$174.11 - $208.62 $94,715 - $113,489
544 Added 26.02%
2,635 $510,000
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $18,003 - $21,104
-108 Reduced 4.91%
2,091 $385,000
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $392,301 - $457,941
2,199 New
2,199 $428,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Erts Wealth Advisors, LLC Portfolio

Follow Erts Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erts Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Erts Wealth Advisors, LLC with notifications on news.